Randomized Double-blind Controlled Exploratory Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
Latest Information Update: 27 Nov 2023
At a glance
- Drugs FB-1006 (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 30 Jun 2023 New trial record